NICOBION 500 mg

DRUG2 trials

Sponsors

Centre Hospitalier Universitaire D Angers, Centre Hospitalier Universitaire D'Angers

Conditions

Dominant Optic AtrophyLeber's Hereditary Optic Neuropathy

Phase 2

Pilot study of the efficacy of nicotinamide (vitamin B3) in Leber's hereditary optic neuropathy - NICOLHON

Not yet recruitingCTIS2025-524343-13-00

Centre Hospitalier Universitaire D'AngersLeber's Hereditary Optic Neuropathy

Target: 13Updated: 2026-03-03

Phase 3

Pilot study of safety and efficacy of nicotinamide (vitamin B3) in OPA1 Dominant Optic Atrophy - NICOPA1-TOL

RecruitingCTIS2023-506214-52-00

Centre Hospitalier Universitaire D AngersDominant Optic Atrophy

Start: 2023-12-27Target: 25Updated: 2024-12-19